About the Authors
- Fanny Porte
-
Roles Conceptualization, Methodology, Supervision, Validation, Writing – review & editing
Affiliation Health Economics Department, Merck Santé S.A.S., Lyon, France
- Anna Granghaud
-
Roles Conceptualization, Methodology, Supervision, Validation, Writing – review & editing
Current address: AbbVie, Rungis, France
Affiliation Health Economics department, Pfizer S.A.S., Paris, France
- Jane Chang
-
Roles Conceptualization, Data curation, Methodology, Supervision, Writing – review & editing
Affiliation Health Economics department, Pfizer, New York, NY, United States of America
- Mairead Kearney
-
Roles Conceptualization, Formal analysis, Methodology, Writing – review & editing
Affiliation Global Value Demonstration, Market Access and Pricing, The Healthcare Business of Merck KGaA, Darmstadt, Germany
- Aya Morel
-
Roles Conceptualization, Resources, Validation
Affiliation Health Economics department, Pfizer S.A.S., Paris, France
- Ingrid Plessala
-
Roles Conceptualization, Formal analysis, Investigation, Methodology, Project administration, Supervision, Validation, Writing – original draft, Writing – review & editing
* E-mail: ingrid.plessala@amaris.com
Affiliation Health Economics & Market Access (HEMA), Amaris Consulting, Paris, France
- Hélène Cawston
-
Roles Conceptualization, Formal analysis, Investigation, Methodology, Project administration, Supervision, Validation, Writing – original draft, Writing – review & editing
Affiliation Health Economics & Market Access (HEMA), Amaris Consulting, Paris, France
- Julie Roiz
-
Roles Conceptualization, Formal analysis, Methodology, Supervision, Validation, Writing – review & editing
Affiliation Health Economics, Evidera, London, United Kingdom
- Ying Xiao
-
Roles Conceptualization, Formal analysis, Methodology, Supervision, Validation, Writing – review & editing
Affiliation Health Economics, Evidera, London, United Kingdom
- Marie-Noelle Solbes
-
Roles Validation, Writing – review & editing
Affiliation Medical Department, Merck Santé S.A.S., Lyon, France
- Prisca Lambert
-
Roles Conceptualization, Validation, Writing – review & editing
Affiliation Medical Department, Pfizer S.A.S., Paris, France
- Alain Ravaud
-
Roles Conceptualization, Formal analysis, Methodology, Writing – review & editing
Affiliation Department of Medical Oncology, Centre Hospitalo-Universitaire de Bordeaux, Bordeaux, France
- Yohann Loriot
-
Roles Conceptualization, Validation, Writing – review & editing
Affiliation Department of Medical Oncology, Institute Gustave-Roussy, Villejuif, France
- Antoine Thiery-Vuillemin
-
Roles Data curation, Investigation, Validation, Visualization, Writing – review & editing
Current address: Bristol Myers Squibb, Boudry, Switzerland
Affiliation Department of Medical Oncology, Centre Hospitalier Régional Universitaire de Besançon, Besançon, France
- Pierre Lévy
-
Roles Conceptualization, Formal analysis, Methodology, Validation, Writing – review & editing
Affiliation Université Paris-Dauphine, Université-PSL, [LEDA], LEGOS, Paris, France
Competing Interests
F. Porte is an employee of Merck Santé S.A.S., Lyon, France, an affiliate of Merck KGaA, Darmstadt, Germany at the time of the project. A. Granghaud was an employee of Pfizer S.A.S., Paris, France at the time of the study. J. Chang is an employee of Pfizer and holds stock and other ownership interest with Bayer, Bristol Myers Squibb, and Pfizer. M. Kearney is an employee of Merck KGaA, Darmstadt, Germany, and holds stock in Merck KGaA, Darmstadt, Germany, Novartis and UCB. A. Morel is an employee of Pfizer S.A.S., Paris, France. I. Plessala was an employee of Amaris Consulting, Paris, France at the time of the study. H. Cawston is an employee of Amaris Consulting, Paris, France. J. Roiz is an employee of and reposts stocks and other ownership interest with Evidera. Y. Xiao is an employee of Evidera. M.-N. Solbes is an employee of Merck Santé S.A.S., Lyon, France, an affiliate of Merck KGaA, Darmstadt, Germany. P. Lambert is an employee of Pfizer S.A.S., Paris, France. A. Ravaud has received grants or contracts from Merck KGaA, Darmstadt, Germany, and Pfizer; has received travel and accommodation expenses from Ipsen Merck KGaA, Darmstadt, Germany, Merck & Co., Kenilworth, NJ, and Pfizer; and has participated in advisory boards for Esai, Ipsen, Merck KGaA, Darmstadt, Germany, and Pfizer. Y. Loriot has served in consulting or advisory roles for Astellas Pharma, Bristol Myers Squibb, Immunomedics, Janssen, Loxo/Lilly, Merck KGaA, Darmstadt, Germany, Merck & Co., Kenilworth, NJ, Pfizer, Roche, Seattle Genetics, and Taiho Pharmaceutical; has received travel and accommodations expenses from Astellas Pharma, Janssen Oncology, Merck & Co., Kenilworth, NJ, Roche, and Seattle Genetics; and has received institutional research funding from Astellas Pharma, Basilea, Bristol Myers Squibb, Exelixis, Gilead Sciences, Incyte, Janssen Oncology, Merck KGaA, Darmstadt, Germany, Merck & Co., Kenilworth, NJ, Nektar, Pfizer, Roche, Sanofi, Seattle Genetics, and Taiho Pharmaceutical. A. Thiery-Vuillemin has participated in advisory boards for Astellas Pharma, AstraZeneca, Bristol-Myers Squibb, Ipsen, Janssen, Merck & Co., Kenilworth, NJ, Novartis, Pfizer, Roche/Genentech and Sanofi; reports employment by Bristol Myers Squibb; has served on steering committees for AstraZeneca, Bristol-Myers Squibb and Novartis; has received institutional research funding from Bayer, Ipsen and Pfizer; has served as principal investigator for Astellas Pharma, AstraZeneca, Bristol-Myers Squibb, Excelixis, Incyte, Ipsen, Johnson & Johnson, Merck & Co., Kenilworth, NJ, Novartis, Pfizer, Roche, Sanofi, and UNICANCER/GETUG; has received travel and accommodation expenses from Astellas Pharma, AstraZeneca, Bristol-Myers Squibb, Ipsen, Johnson & Johnson, Merck & Co., Kenilworth, NJ, Pfizer and Roche; and is a member of ASCO and GETUG. P. Lévy has served in consulting or advisory role and had received honoraria from Merck KGaA, Darmstadt, Germany. This does not alter our adherence to PLOS ONE policies on sharing data and materials